NYSE - Nasdaq Real Time Price USD

Medifast, Inc. (MED)

Compare
16.44 -0.14 (-0.84%)
As of 3:54:32 PM EST. Market Open.
Loading Chart for MED
DELL
  • Previous Close 16.58
  • Open 16.60
  • Bid 16.45 x 1100
  • Ask 16.51 x 1000
  • Day's Range 16.41 - 17.62
  • 52 Week Range 16.41 - 66.51
  • Volume 207,222
  • Avg. Volume 211,145
  • Market Cap (intraday) 179.817M
  • Beta (5Y Monthly) 1.16
  • PE Ratio (TTM) 24.54
  • EPS (TTM) 0.67
  • Earnings Date Feb 18, 2025 - Feb 24, 2025
  • Forward Dividend & Yield 6.60 (34.41%)
  • Ex-Dividend Date Sep 18, 2023
  • 1y Target Est 16.50

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

medifastinc.com

634

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MED

View More

Performance Overview: MED

Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

MED
7.59%
S&P 500
0.02%

1-Year Return

MED
74.51%
S&P 500
25.72%

3-Year Return

MED
91.68%
S&P 500
25.76%

5-Year Return

MED
82.46%
S&P 500
81.92%

Compare To: MED

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MED

View More

Valuation Measures

As of 1/6/2025
  • Market Cap

    181.35M

  • Enterprise Value

    29.02M

  • Trailing P/E

    24.75

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.27

  • Price/Book (mrq)

    0.87

  • Enterprise Value/Revenue

    0.04

  • Enterprise Value/EBITDA

    1.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.09%

  • Return on Assets (ttm)

    4.77%

  • Return on Equity (ttm)

    3.66%

  • Revenue (ttm)

    674.48M

  • Net Income Avi to Common (ttm)

    7.33M

  • Diluted EPS (ttm)

    0.67

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    169.96M

  • Total Debt/Equity (mrq)

    8.50%

  • Levered Free Cash Flow (ttm)

    -7.09M

Research Analysis: MED

View More

People Also Watch